P54 Screening for primary aldosteronism in hypertensive patients with systemic lupus erythematosus:...
P54 Screening for primary aldosteronism in hypertensive patients with systemic lupus erythematosus: are we doing it enough?
About this item
Full title
Author / Creator
Publisher
London: Lupus Foundation of America
Journal title
Language
English
Formats
Publication information
Publisher
London: Lupus Foundation of America
Subjects
More information
Scope and Contents
Contents
ObjectiveCardiovascular disease is one of the two leading causes of mortality in systemic lupus erythematosus (SLE). Hypertension, a traditional cardiovascular risk factor, is highly prevalent in SLE. Primary aldosteronism (PA), the most common endocrine cause of hypertension, remains under-screened and under-diagnosed, despite targeted treatment a...
Alternative Titles
Full title
P54 Screening for primary aldosteronism in hypertensive patients with systemic lupus erythematosus: are we doing it enough?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b33a4c97c9a2499a8548d1f48ff5188f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b33a4c97c9a2499a8548d1f48ff5188f
Other Identifiers
E-ISSN
2053-8790
DOI
10.1136/lupus-2024-el.108
